Faeth Therapeutics, Inc. — Form D

Faeth Therapeutics, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-27. The offering totals $25.0M, of which $24.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-01-27
• Form: D
• Accession: 0002100543-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $25.0M
• Amount sold: $24.4M
• Remaining: $566K
• Investors: 35
• Date of first sale: 2025-08-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-571199

Issuer

• Name: Faeth Therapeutics, Inc.
• CIK: 0002100543
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 701 TILLERY ST #12 #1010, AUSTIN, TX, 78702
• Phone: 510-858-1839

Officers, directors & promoters (9)

More

• CIK 2100543 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search